285
Views
7
CrossRef citations to date
0
Altmetric
Cardiovascular: Original articles

Prostacyclin and its analogues in pulmonary artery hypertension: a meta-analysis

, , , , &
Pages 889-899 | Accepted 02 May 2013, Published online: 05 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xi Gu, Ying Wang, Hanxun Wang, Hairui Wu, Wei Li, Jian Wang & Ning Li. (2021) Homology modeling, molecular dynamics and virtual screening of endothelin-A receptor for the treatment of pulmonary arterial hypertension. Journal of Biomolecular Structure and Dynamics 39:11, pages 3912-3923.
Read now
Shirin Bruderer, Noémie Hurst, Tatiana Remenova & Jasper Dingemanse. (2017) Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension. Expert Opinion on Drug Safety 16:6, pages 743-751.
Read now

Articles from other publishers (5)

Pengwei Wang, Jiaxin Deng, Quanying Zhang, Hongyan Feng, Yongheng Zhang, Yizhong Lu, Lizhu Han, Pengfei Yang & Zhijian Deng. (2022) Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis. Frontiers in Pharmacology 13.
Crossref
Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung & Andreas Karabis. (2020) Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal. BMC Pulmonary Medicine 20:1.
Crossref
Megan L. Sulciner, Allison Gartung, Molly M. Gilligan, Charles N. Serhan & Dipak Panigrahy. (2018) Targeting lipid mediators in cancer biology. Cancer and Metastasis Reviews 37:2-3, pages 557-572.
Crossref
Huijun Zhang, Xiaobing Li, Jiancheng Huang, Hongying Li, Zhenyu Su & Jun Wang. (2016) Comparative Efficacy and Safety of Prostacyclin Analogs for Pulmonary Arterial Hypertension. Medicine 95:4, pages e2575.
Crossref
Yaguo Zheng, Tao Yang, Guo Chen, Enci Hu, Qing Gu & Changming Xiong. (2013) Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomes. European Journal of Clinical Pharmacology 70:1, pages 13-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.